Near-Terminal Leukemia Patients In Remission As Experimental Drug Raises Hope
Acute myeloid leukemia is the most common blood cancer in adults, with 120,000 cases new cases being diagnosed every year. Unfortunately, the three-year survival rate is just 25% for the disease.
Read Original Article: Near-Terminal Leukemia Patients In Remission As Experimental Drug Raises Hope »
